72351-59-8 Usage
Description
Ethyl 1,4-dibenzylpiperazine-2-carboxylate is an organic compound that serves as a key reactant in the synthesis of various chemical compounds, particularly in the preparation of (benzyl)(alkyl)(imidazolyl)piperazines and their isoteric analogs. It is characterized by its unique chemical structure, which contributes to its reactivity and utility in chemical synthesis.
Uses
Used in Pharmaceutical Industry:
Ethyl 1,4-dibenzylpiperazine-2-carboxylate is used as a reactant for the synthesis of (benzyl)(alkyl)(imidazolyl)piperazines and isoteric analogs, which are important in the development of new pharmaceutical compounds. These synthesized compounds have potential applications in the treatment of various medical conditions, making Ethyl 1,4-dibenzylpiperazine-2-carboxylate a valuable component in the pharmaceutical industry.
Used in Chemical Research:
In addition to its pharmaceutical applications, Ethyl 1,4-dibenzylpiperazine-2-carboxylate is also used as a reactant in chemical research. Its unique structure allows for the exploration of new chemical reactions and the development of novel compounds with potential applications in various fields, including materials science, agriculture, and environmental science.
Check Digit Verification of cas no
The CAS Registry Mumber 72351-59-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,3,5 and 1 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 72351-59:
(7*7)+(6*2)+(5*3)+(4*5)+(3*1)+(2*5)+(1*9)=118
118 % 10 = 8
So 72351-59-8 is a valid CAS Registry Number.
InChI:InChI=1/C21H26N2O2/c1-2-25-21(24)20-17-22(15-18-9-5-3-6-10-18)13-14-23(20)16-19-11-7-4-8-12-19/h3-12,20H,2,13-17H2,1H3
72351-59-8Relevant articles and documents
TRICYCLIC PYRIDONES AND PYRIMIDONES
-
Paragraph 0789; 0793-0794, (2021/06/26)
A compound of Formula (I) is provided: (I) where the variables are defined herein.
SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF
-
Page/Page column 35, (2018/03/01)
Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
QUINOLINE DERIVATIVES AS SMO INHIBITORS
-
Paragraph 0110; 0111, (2017/02/28)
Disclosed are quinoline derivatives as hedgehog pathway inhibitors, especially as SMO inhibitors. Compounds of the present invention can be used in treating diseases relating to hedgehog pathway including cancer.